2McMurray J J, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail, 2012, 14: 803-869.
3Leyva F, Nisam S, Auricchio A. 20 years of cardiac resynchronization therapy. J Am Coil Cardiol, 2014, 64: 1047-1058.
4Shetty AK, Duekeu SG, Bostock J, et al. Use of a quadripolar left ventricular lead to achieve successful implantation in patients with previous failed attempts at cardiac resynchronization therapy. Europace, 2011, 13: 992-996.
5Pappone C, Caloric Z, Vicedomini G, et al. Improving cardiac resynchronization therapy response with multipoint left ventricular pacing: Twelve-month follow-up study. Heart Rhythm, 2015, 12: 1250-1258.
6Bettin M, Reinke F, Rath B, et al. Recent advances in the entirely subcutaneous ICD System. F1000Prime Rep, 2015, 7: 46.
7Burke MC, Gold MR, Knight BP, et al. Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. J Am Coil Cardiol, 2015, 65: 1605-1615.
8Priori SG, Blomstrom-Lnndqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J, 2015, 36: 2793- 2867.
9Chung MK, Szymkiewicz S J, Shao M, et al. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coil Cardiol, 2010, 56: 194-203.
10Klein HU, Goldenherg I, Moss AJ. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Eur Heart J, 2013, 34: 2230-2242.
